Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T15:36:23.042Z.
Calculation as of: 2026-10-06T15:36:23.042Z.
Quote observation: 2026-10-06T15:34:58.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4140271b5ba2e17517ffa776ba39ee0784cb590c71b20d0313403f3757235181
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$1.15B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.15B
Price/FCF Ratio
7.91
TTM Avg
9.04
3Y Avg
20.26
5Y Avg
32.54
Market Cap
$1.21B
Price/FCF Ratio
24.02
TTM Avg
28.25
3Y Avg
29.31
5Y Avg
46.12
Market Cap
$1.13B
Price/FCF Ratio
7.42
TTM Avg
8.70
3Y Avg
12.19
5Y Avg
18.11
Market Cap
$1.13B
Price/FCF Ratio
213.92
TTM Avg
118.53
3Y Avg
218.34
5Y Avg
165.60
Market Cap
$1.22B
Price/FCF Ratio
N/A
TTM Avg
60.78
3Y Avg
115.25
5Y Avg
115.25
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.17B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.17B | N/A | 9.27 | 9.27 | 9.27 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.15B | N/A | N/A | N/A | N/A |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 7.91 | 9.04 | 20.26 | 32.54 |
| OPKO Health, Inc. (OPK)vs › | $1.14B | N/A | 98.87 | 158.25 | 159.34 |
| Innovage Holding Corp. (INNV)vs › | $1.21B | 24.02 | 28.25 | 29.31 | 46.12 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 7.42 | 8.70 | 12.19 | 18.11 |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 213.92 | 118.53 | 218.34 | 165.60 |
| MannKind Corporation (MNKD)vs › | $1.22B | N/A | 60.78 | 115.25 | 115.25 |
| Omada Health (OMDA)vs › | $1.22B | 60.77 | 62.80 | 62.80 | 62.80 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
